Compare OBT & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | OBT | USBC |
|---|---|---|
| Founded | 1892 | N/A |
| Country | United States | |
| Employees | N/A | 6 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.1M | 317.5M |
| IPO Year | N/A | N/A |
| Metric | OBT | USBC |
|---|---|---|
| Price | $26.87 | $0.74 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $29.00 | N/A |
| AVG Volume (30 Days) | ★ 19.5K | N/A |
| Earning Date | 10-29-2025 | N/A |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | ★ 18.38 | N/A |
| EPS | ★ 3.03 | N/A |
| Revenue | ★ $115,418,000.00 | N/A |
| Revenue This Year | $19.86 | N/A |
| Revenue Next Year | $7.20 | N/A |
| P/E Ratio | $8.94 | ★ N/A |
| Revenue Growth | ★ 17.75 | N/A |
| 52 Week Low | $20.97 | N/A |
| 52 Week High | $30.81 | N/A |
| Indicator | OBT | USBC |
|---|---|---|
| Relative Strength Index (RSI) | 59.65 | 41.66 |
| Support Level | $25.01 | $0.71 |
| Resistance Level | $27.72 | $0.87 |
| Average True Range (ATR) | 0.72 | 0.09 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 58.03 | 19.51 |
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.